α1-Adrenoceptors in the urinary tract

Handbook of Experimental Pharmacology

Volumn 202, Issue , 2011, Pages 283-306

  Yamada, Shizuo ^a   Ito, Yoshihiko ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

1 Adrenoceptor antagonists; 1 Adrenoceptor subtypes; Lower urinary tract symptom; Urinary tract

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; DOXAZOSIN; MESSENGER RNA; PRAZOSIN; SILODOSIN; TAMSULOSIN; TERAZOSIN;

ARTICLE; ASTHENIA; BINDING AFFINITY; BLADDER CONTRACTION; BLADDER MUSCLE; CENTRAL NERVOUS SYSTEM; DIARRHEA; DIZZINESS; DRUG DOSE TITRATION; DYSPNEA; EDEMA; EJACULATION DISORDER; FATIGUE; FLU LIKE SYNDROME; GANGLION; HEADACHE; HUMAN; HYPOTENSION; IMPOTENCE; INFECTION; LIGAND BINDING; LOWER URINARY TRACT SYMPTOM; MOLECULAR BIOLOGY; MOLECULAR CLONING; NAUSEA; NERVE ENDING; NONHUMAN; NOSE CONGESTION; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BINDING; RHINITIS; SENSORY NERVE; SOMNOLENCE; URETER; URETHRA PRESSURE; URINARY TRACT FUNCTION; UROTHELIUM; VAS DEFERENS; VASCULAR TISSUE; XEROSTOMIA; ANIMAL; BLADDER; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; INNERVATION; MALE; METABOLISM; REVIEW; URETHRA; URINARY TRACT;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ANIMALS; CENTRAL NERVOUS SYSTEM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; PROSTATE; RECEPTORS, ADRENERGIC, ALPHA-1; RNA, MESSENGER; URETER; URETHRA; URINARY BLADDER; URINARY TRACT;

EID: 79952209063     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-16499-6_14     Document Type: Article

References (144)

1. Abrams P, Tammela TL, Hellström P, Marberger M, Djavan BR, Lunglmayr G, Panos P, Labal KU (1998) European pressure-flow investigation of tamsulosin in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) - ESPRIT study. J Urol 159:256
2. 1a, antagonist, tested in a novel rat model. J Pharmacol Exp Ther 291:81-91
3. Andersson KE (2002) Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists, World J Urol 19:390-396
4. Andersson KE, Gratzke C (2007) Pharmacology of ai-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol 4:368-378
5. Andersson KE, Larsson B, Sjogren C (1984) Characterization of the a-adrenoceptors in the female rabbit urethra. Br J Pharmacol 81:293-300 (Pubitemid 14149406)
6. Beach MA, Mauro LS (2006) Pharmacologic expulsive treatment of ureteral calculi, Ann Pharmacother 40:1361-1368 (Pubitemid 44204967)
7. Birder LA, de Groat WC (2007) Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat Clin Pract Urol 4:46-54 (Pubitemid 46062986)
8. Boyle P, Napalkov P (1995) The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension. Scand J Urol Nephrol Suppl 168:7-12
9. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136
10. Caine M, Raz S, Zeigler M (1975) Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 47:193-202
11. Chang RS, Chen TB, O'Malley SS, Pettibone DJ, DiSalvo J, Francis B, Bock MG, Freidinger R, Nagarathnam D, Miao SW, Shen Q, Lagu B, Murali Dhar TG, Tyagarajan S, Marzabadi MR, Wong WC, Gluchowski C, Forray C (2000) In vitro studies on L-771,688 (SNAP 6383), a new potent and selective α1a-adrenoceptor antagonist. Eur J Pharmacol 409:301-312
12. Chappie CR, Aubry ML, James S, Greengrass PM, Burnstock G, Turner-Warwick RT, Milroy EJ, Davey MJ (1989) Characterization of human prostatic adrenoceptors using pharmacology receptor binding and localization, Br J Urol 63:487-496 (Pubitemid 19134149)
13. Chen Q, Takahashi S, Zhong S, Hosoda C, Zheng HY, Ogushi T, Fujimura T, Ohta N, Tanoue A, Tsujimoto G, Kitamura T (2005) Function of the lower urinary tract in mice lacking otiaadrenoceptor. J Urol 174:370-374 (Pubitemid 40825760)
14. Chueh SC, Guh JH, Chen J, Lai MK, Ko FN, Teng CM ( 1996) Inhibition by tamsulosin of tension responses of human hyperplastic prostate to electrical field stimulation. Eur J Pharmacol 305:177-180 (Pubitemid 26197604)
15. 1 adrenergic receptor antagonist prazosin. J Urol 153:1308-13120
16. 1d- adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat 13:115-139
17. de Groat WC, Booth AM, Yoshimura N (1993) Neurophysiology of micturition and its modification in animal models of human disease. In: Maggi CA (ed) The autonomic nervous system nervous control of the urogenital system, vol 6. Harwood Academic Publishers, London, p 227
18. de Mey C, Michel MC, McEwen J, Moreland T (1998) A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. Eur Urol 33:481-488 (Pubitemid 28251997)
19. 1 adrenoceptor subtypes mediate contraction in rabbit prostate and hypogastric artery. Acta Physiol Scand 1.58:241-251
20. 1d- adrenoceptor subtype in rat myocardium, aorta and other tissues. Br J Pharmacol 119:269-276
21. Deplanne V, Palea S, Angel I (1998) The adrenergic, cholinergic and NANC nerve-mediated contractions of the female rabbit bladder neck and proximal, medial and distal urethra, Br J Pharmacol 123:1517-1524 (Pubitemid 28182033)
22. 1A adrenergic receptor mRNA in the rat brain visualized by in situ hybridization. J Comp Neurol 386:358-378
23. 1D-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 363:649-662
24. Fine SR, Ginsberg P (2008) Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications. J Am Osteopath Assoc 108:333-337
25. 1c subtype. Mol Pharmacol 45:703-708
26. Fulton B, Wagstaff AJ, Sorkin EM (1995) Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. Drugs 49:295-320
27. 1-adrenoceptor subtypes in tension response of human prostate to electrical field stimulation. Br J Pharmacol 115:142-146
28. Guilmard C, Auguet M, Chabrier PE (1996) Pharmacological characterization of alpha1 -adrenoceptor subtype mediating regulation of arterial pressure and urethral perfusion pressure in the anaesthetized rat, J Auton Pharmacol 16:197-203 (Pubitemid 26396375)
29. Guimaraes S, Moura D (2001) Vascular adrenoceptors: an update, Pharmacol Rev 53:319-356 (Pubitemid 32476119)
30. Hampel C, Dolber PC, Smith MP, Savic SL, JW Throff, Thor KB, Schwinn DA (2002) Modulation of bladder α1-adrenergic receptor subtype expression by bladder outlet obstruction. J Urol 167:1513-1521 (Pubitemid 34132142)
31. Harada K, Ohmori M, Kitoh Y, Sugimoto K, Fujimura A (1999) A comparison of the antagonistic activities of tamsulosin and terazosin against human vascular α1 -adrenoceptors. Jpn J Pharmacol 80:209-215 (Pubitemid 29381088)
32. 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery. Br J Pharmacol 113:723-728
33. 1- adrenoceptor subtype signaling and genomic organization. Trends Pharmacol Sci 25:449-455
34. 1adrenoceptor subtypes in the rabbit prostate. J Auton Pharmacol 15:271-278
35. Hirasawa A, Horie K, Tanaka T, Takagaki K, Murai M, Yano J, Tsujimoto G (1993) Cloning, functional expression and tissue distribution of human cDNA for the α1c- adrenergic receptor, Biochem Biophys Res Commun 195:902-909 (Pubitemid 23280501)
36. Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT, Hollenbeck BK (2006) Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 368: 1171-1179 (Pubitemid 44441578)
37. 1- Adrenoceptor subtype mediating contraction of the smooth muscle in the lower urinary tract and prostate of rabbits. Naunyn Schmiedebergs Arch Pharmacol 330:16-21
38. 1D adrenergic receptors in the rat urothelium facilitates the micturition reflex. J Urol 175:358-364
39. Ishizuka O, Persson K, Mattiasson A, Naylor A, Wyllie M, Andersson KE (1996) Micturition in conscious rats with and without bladder outlet obstruction: role of spinal apdrenoceptors. Br J Pharmacol 117:962-966 (Pubitemid 26075974)
40. 1-adrenoceptor blockade. Naunyn Schmiedebergs Arch Pharmacol 355:787-793
41. Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K (2007) Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 14:749-753 (Pubitemid 47206773)
42. Jensen BC, Swigart PM, Simpson PC (2009) Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific. Naunyn-Schmiedebergs Arch Pharmacol 379:409-412
43. 2- adrenoceptors on bladder activity induced by bladder distension in anaesthetized rat. BJU Int 85:925-931
44. Kawabe K (1998) Current status of research on prostate-selective alpha 1-antagonists. Br J Urol 81 (Suppl 1):48-50
45. Kawabe K, Moriyama N, Hamada K, Ishima T (1990) Density and localization of alphap adrenoceptors in hypertrophied prostate. J Urol 143:592-595 (Pubitemid 20108172)
46. Kawabe K, Moriyama N, Yamada S, Taniguchi N (1994) Rationale for the use of α-blockers in the treatment of benign prostatic hyperplasia (BPH). Int J Urol 1:203-211
47. 2-adrenoceptors. Am J Physiol 258:R44-50
48. 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. Urology 44:52-57
49. 1- adrenoceptors: binding, functional and in vivo studies. Br J Pharmacol 118:871-878
50. 2 receptors in serotonin-induced contraction of rat prostate: autoradiographical and functional studies, Eur J Pharmacol 273:7-14
51. Kobayashi S, Tang R, Shapiro E, Lepor H (1993) Characterization and localization of prostatic alpha 1 adrenoceptors using radioligand receptor binding on slide-mounted tissue section, J Urol 150:2002-2006 (Pubitemid 24350853)
52. 1 -adrenoceptor subtypes in mouse ureter, World J Urol, doi: 10.1007/s00345-009-0396-y
53. 1-adrenoceptor subtypes in dog intravesical ureter. Urology 74:458-462
54. Kunisawa Y, Kawabe K, Niijima T, Honda K, Takenaka T (1985) A pharmacological study of alpha adrenergic receptor subtypes in smooth muscle of human urinary bladder base and prostatic urethra. J Urol 134:396-398 (Pubitemid 15006583)
55. Küpeli B, Irkilate L, Giirocak S, Tunc L, Kiraç M, Karaoglan U, Bozkirli I (2004) Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? Urology 64:1111-1115
56. 1A adrenergic receptor antagonist with high oral bioavailability, J Med Chem 43:2775-2778
57. Larsson B, Sjogren C, Andersson KE (1986) Regional distribution of a-adrenoceptor subtypes in the female rabbit urethra. Acta Physiol Scand 126:39-43 (Pubitemid 16061103)
58. 1-adrenoceptor antagonist in the lower urinary tract. Br J Pharmacol 109:1282-1289
59. Lepor H (1998) Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia, Tamsulosin Investigator Group. Urology 51:892-900
60. Lepor H, Lowe FC (2002) Evaluation and nonsurgical management of benign prostatic hyperplasia. In: Walch PC, Tetik AB, Vaughan ED (eds) Campbell's urology, 8th edn. WB Saunders CO, Philadelphia, pp 1337-1378
61. Lepor H, Zhang W, Kobayashi S, Tang R, Wang B, Shapiro E ( 1994) A comparison of the binding and functional properties of Alpha-1 adrenoceptors and area density of smooth muscle in the human, canine and rat prostates. J Pharmacol Exp Ther 270:722-727
62. Levin RM, Ruggieri MR, Wein AJ (1988) Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding. J Urol 139:844-848
63. Lluel P, Deplanne V, Heudes D, Bruneval P, Palea S (2003) Age-related changes in urethrovesical coordination in male rats: relationship with bladder instability? Am J Physiol Regul Integr Comp Physiol 284:R1287-1295
64. Malloy BJ, Price DT, Price RR, Bienstock AM, Dole MK, Funk BL, Rudner XL, Richardson CD, Donatucci CF, Schwinn DA (1998) α1-adrenergic receptor subtypes in human detrusor. J Urol 160:937-943 (Pubitemid 29479558)
65. Marks LS, Gittelman MC, Hill LA, Volinn W, Hoel G (2009) Silodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: a 9-month, open-label extension study, Urol 74:1318-1322
66. 1c-) adrenoceptor subtype. Br J Pharmacol 115:781-786
67. Martin DJ, Lluel P, Guillot E, Coste A, Jammes D, Angel I (1997) Comparative Alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of Alpha-1 adrenoceptor antagonists. J Pharmacol Exp Ther 282:228-235 (Pubitemid 27425545)
68. 1L) in bovine prostate and rat heart and brain, Gen Pharmacol 31:597-600
69. Menon M, Parulkar BG, Drach DW (1998) Urinary lithiasis: etiology, diagnosis and medical management. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell's urology, vol 3, 7th edn. WB Saunders, Philadelphia, p 2702
70. Michel MC (2010) The foreront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: α-blocker in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability? J Pharmacl Sci 112:151-157
71. Michel MC, de la Rosette JJ (2006) α-blocker treatment of urolithiasis. Eur Urol 50:213-214
72. 2- and β-adrenoeeptors in the urinary bladder, urethra and prostate. BrJ Pharmacol 147:S88-S119
73. 1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol 16:21-28
74. 1-adrenoceptor antagonists. BJU International 95(Suppl 4): 29-36
75. Monneron MC, Gillberg PG, Ohman B, Alberts P (2000) In vitro α-adrenoceptor autoradiography of the urethra and urinary bladder of the female pig, cat, guinea-pig and rat. Scand J Urol Nephrol 34:233-238
76. Morita T, Wada I, Suzuki T, Tsuchida S (1987) Characterization of α-adrenoceptor subtypes involved in regulation of ureteral fluid transport. Tohoku J Exp Med 152:111-118 (Pubitemid 17137763)
77. Morita T, Ando M, Kihara K, Oshima H (1994) Function and distribution of autonomic receptors in canine ureteral smooth muscle. Neurourol Urodyn 13:315-321 (Pubitemid 24196862)
78. 1-adrenoceptors in vascular smooth muscle. Br J Pharmacol 99:197-201
79. Nakamura Y, Tsujimoto G, Tanoue A, Ikegaki I, Shinozaki S, Nimura T, Matsuda Y, Kawatani M (2004) Is alpha-ID adrenergic receptor responsible for storage symptoms in mice?: effects of acetic acid on bladder function in mice lacking alpha-ID adrenergic receptor. Neurourol Urodyn 23:508
80. Narayan P, O'Leary M, Davidai G (2005) Early efficacy of tamsulosin vs. terazosin in the treatment of men with benign prostatic hyperplasia: a randomized, open-label trial. J Appl Res 5:237-245 (Pubitemid 40962167)
81. 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue. BrJ Pharmacol 119:797-803
82. 1-adrenoceptor subtype mRNAs in human proximal urethra. Br J Pharmacol 123:1289-1293
83. 1B- adrenoceptor subtypes. BrJ Pharmacol 120:231-238
84. Nomiya M, Yamaguchi O (2003) A quantitative analysis of mRNA expression of α1 and β-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 170:649-653 (Pubitemid 36870277)
85. Oesterling JE (1996) Benign prostatic hyperplasia: a review of its histogenesis and natural history, Prostate Suppl 6:67-73
86. Ohkura T, Yamada S, Deguchi Y, Kimura R, Matsushima H, Higuchi S, Inagaki O, Honda K, Takenaka T (1998) Ex vivo occupancy by tamsulosin of ai-adrenoceptors in rat tissues in relation to the plasma concentration. Life Sci 63:2147-2155 (Pubitemid 28545174)
87. 1-adrenoceptors by oral administration of KMD-3213 and its plasma concentration in rats. J Pharm Pharmacol 54:975-982
88. 1-adrenoceptor subtypes in the dog prostate. Urol Res 21:211-215
89. Ohtake A, Ukai M, Saitoh C, Sonoda R, Noguchi Y, Okutsu H, Yuyama H, Sato S, Sasamata M, Miyata K (2006) Effect of tamsulosin on spontaneous bladder contraction in conscious rats with bladder outlet obstruction: comparison with effect on intraurethral pressure. Eur J Pharmacol 545:185-191
90. Okutsu H, Matsumoto S, Hanai T, Noguchi Y, Fujiyasu N, Ohtake A, Suzuki M, Sato S, Sasamata M, Uemura H, Kurita T (2010) Effects of tamsulosin on bladder blood flow and bladder function in rats with bladder outlet obstruction. Urol 75:235-240
91. Parsons JK, Hergan LA, Sakamoto K, Lakin C (2007) Efficacy of a-blockers for the treatment of urethral stones. J Urol 177:983-987 (Pubitemid 46216377)
92. Pradidarcheep W, Stallen J, Labruyere WT, Dabhoiwala NF, Michel MC, Lamers WH (2009) Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors. Naunyn-Schmiedebergs Arch Pharmacol 379:397-402
93. 1 adrenergic receptor subtypes in human prostate. J Urol 150:546-551
94. Ramage AG, Wyllie MG (1995) A comparison of the effects of doxazosin and terazosin on the spontaneous sympathetic drive to the bladder and related organs in anaesthetized cats. Eur J Pharmacol 294:645-650 (Pubitemid 26013247)
95. Sasaki S, Itoh Y, Kojima Y, Kubota Y, Hayase M, Kobayashi M, Tomiyama Y, Kobayashi S, Kohri K (2008) Expression level and role in ureteral contraction of alphal-adrenoceptor subtypes in human ureter. Neurourol Urodyn 179(suppl):244
96. Sato S, Ohtake A, Matsushima H, Saitoh C, Usuda S, Miyata K (2001) Pharmacological effect of tamsulosin in relation to dog plasma and tissue concentrations: prostatic and urethral retention possibly contributes to uroselectivity of tamsulosin. J Pharmacol Exp Ther 296:697-703 (Pubitemid 32187337)
97. 1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia. Clin Ther 31:2489-2502
98. Schulman CC (1974) Electron microscopy of the human ureteric innervation, Br J Urol 46:609-623
99. 1-adrenergic receptor subtypes in lower urinary tract symptoms, BJU Int 88(Suppl 2):27-34, discussion 49-50
100. 1-Adrenergic receptors in the lower urinary tract and vascular bed: potential role for the alphald subtype in filling symptoms and effects of ageing on vascular expression. BJU Int 85(Suppl 2):6-11
101. 1-adrenoceptor subtypes and lower urinary tract symptoms, Int J Urol 15:193-199
102. Scofield MA, Liu F, Abel PW, Jeffries WB (1995) Quantification of steady state expression of mRNA for Alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J Pharmacol Exp Ther 275:1035-1042
103. Sigala S, Peroni A, Mirabella G, Fornari S, Palazzolo F, Pezzotti G, Simeone C, Cunico SC, Spano P (2004) Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. Life Sci 76:417-427 (Pubitemid 39458310)
104. 1 -adrenoceptor subtypes in the human ureter. Neurourol Urodyn 24:142-148
105. 1-adrenergic receptor subtypes at four distinct levels, Brain Res Mol Brain Res 63:254-261
106. 1-adrenoceptors in the rat urinary bladder. Br J Pharmacol 114:1710-1716
107. Springer JP, Kropp BP, Thor KB (1994) Facilitatory and inhibitory effects of selective norepinephrine reuptake inhibitors on hypogastric nerve-evoked urethral contractions in the cat: a prominent role of urethral β-adrenergic receptors. J Urol 152:515-519 (Pubitemid 24221265)
108. Sugaya K, Nishijima S, Miyazato M, Ashitomi K, Hatano T, Ogawa Y (2002) Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -ID adrenergic receptor antagonists, on bladder activity in rats. Neurosci Lett 328:74-76 (Pubitemid 34786047)
109. Suzuki F, Miyamoto S, Takita M, Oshita M, Watanabe Y, Kakizuka A, Narumiya S, Taniguchi T, Muramatsu I (1997) Cloning, functional expression and tissue distribution of rabbit α1dadrenoceptor. Biochim Biophys Acta 1323:6-11 (Pubitemid 27051428)
110. Szell EA, Yamamoto T, de Groat WC, Somogyi GT (2000) Smooth muscle and parasympathetic nerve terminals in the rat urinary bladder have different subtypes of α1 adrenoceptors. Br J Pharmacol 130:1685-1691 (Pubitemid 30611949)
111. Takeda H, Matsuzawa A, Igawa Y, Yamazaki Y, Kaidoh K, Akahane S, Kojima M, Miyata H, Akahane M, Nishizawa O (2003) Functional characterization of β-adrenoeeptor subtypes in the canine and rat lower urinary tract. J Urol 170:654-658 (Pubitemid 36870278)
112. 1-Adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213), Yakugaku Zasshi 126:209-216
113. 1 -adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man. Eur J Pharmacol 249:307-315
114. Thor KB, Donatucci C (2004) Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women. J Urol 172:27-33 (Pubitemid 41615033)
115. Tiselius HG (2003) Epidemiology and medical management of stone disease. BJU Int 91:758-767
116. Tomiyama Y, Murakami M, Akiyama K, Kojima M, Akahane M, Park YC, Kurita T (2002) Modification of ureteral motility and promotion of urine flow around an intraureteral obstruction by CL-316243, phenylephrine, and furosemide in dogs. Neurourol Urodyn 21:251-257 (Pubitemid 34411844)
117. 1- adrenoceptor subtypes in hamster ureter. Eur J Pharmacol 573:201-205
118. Trevisani M, Campi B, Gatti R, Andre E, Materazzi S, Nicoletti P, Gazzieri D, Geppetti P (2007) The influence of Alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract. Eur Urol 52:901-908 (Pubitemid 47126136)
119. 1c-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types. Br J Pharmacol 115:1475-1485
120. Tsujii T, Azuma H, Yamaguchi T, Oshima H (1992) A possible role of decreased relaxation mediated by β-adrenoceptors in bladder outlet obstruction by benign prostatic hyperplasia. Br J Pharmacol 107:803-807
121. Tzortzis V, Mamoulakis C, Rioja J, Gravas S, Michel MC, De la Rosette JJMCH (2009) Medical expulsive therapy for distal ureteral stones. Drugs 69:677-692
122. 1a- adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate. J Urol 157:1032-1038
123. 1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate. J Urol 161:635-640
124. Wanajo I, Tomiyama Y, Tadachi M, Kobayashi M, Yamazaki Y, Kojima M, Shibata N (2005) The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics. Urol Res 33:409-414 (Pubitemid 41778779)
125. Weiss RM, Bassett AL, Hoffman BF (1978) Adrenergic innervation of the ureter. Invest Urol 16:123-127 (Pubitemid 9157410)
126. Wilde MI, Fitton A, McTavish D (1993a) Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs 45:410-429
127. Wilde MI, Fitton A, Sorkin EM (1993b) Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs Aging 3:258-277
128. Yamada S, Ashizawa N, Ushijima H, Nakayama K, Hayashi E, Honda K (1987) Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy. J Pharmacol Exp Ther 242:326-330
129. 3H] bunazosin, a novel selective radioligand of alpha 1 adrenoceptors in human prostates. J Urol 146:877-880
130. Yamada S, Suzuki M, Kato Y, Kimura R, Mori R, Matsumoto K, Maruyama M, Kawabe K (1992) Binding characteristics of naftopidil and alpha 1-adrenoceptor antagonists to prostatic alphaadrenoceptors in benign prostatic hypertrophy. Life Sci 50:127-135
131. 1 -adrenoceptor antagonist binding in human prostate and aorta. Clin Exp Pharmacol Physiol 21:405-411
132. Yamada S, Tanaka C, Kimura R, Kawabe K (1994b) Alpha 1-adrenoceptors in human prostate: characterization and binding characteristics of alpha 1-antagonists. Life Sci 54:1845-1854
133. Yamada S, Tanaka C, Ohkura T, Mori R, Kimura R, Inagaki O, Honda K, Kawabe K (1994c) High-affinity specific [3H]tamsulosin binding to alpha 1-adrenoceptors in human prostates with benign prostatic hypertrophy. Urol Res 22:273-278 (Pubitemid 24369380)
134. Yamada S, Ohkura T, Kimura R, Kawabe K (1998) In vivo receptor binding of novel alpha 1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia. Life Sci 62:1585-1589
135. 3H]tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics. J Pharmacol Exp Ther 289:1575-1583
136. 1-adrenoceptor subtype selectivity of KMD-3213 in rat tissues. J Pharmacol Exp Ther 296:160-167
137. 1a-adrenoceptorselective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta. Eur J Pharmacol 315:73-79
138. 1-adrenoceptor subtype in the rat prostate is preferentially the alpha IA type. Jpn J Pharmacol 62:297-304
139. 1-adrenergic blockers for distal ureteral stones. J Urol 173:2010-2012
140. 1-blocker depends on the suppression of C-fiber afferent activity in rats. Neurourol Urodyn 25:461-467
141. Yokoyama O, Yusup A, Oyama N, Aoki Y, Miwa Y, Akino H (2007) Improvement in bladder storage function by tamsulosin depends on suppression of C-fiber urethral afferent activity in rats, J Urol 177:771-775 (Pubitemid 46053998)
142. 1A-adrenoceptor mRNA in the rat lower urinary tract. Can J Physiol Pharmacol 82:872-878
143. Yoshimura N, Sasa M, Ohno Y, Yoshida O, Takaori S (1988) Contraction of urinary bladder by central norepinephrine originating in the locus coeruleus. J Urol 139:423-427
144. 1-adrenoceptor antagonist, on human hyperplastic prostates. Eur J Pharmacol 252:29-34